Pfizer has spent years on the receiving end of the FDA's wrath for continued manufacturing issues surrounding the drugmaker's 2015 buyout of Hospira. Now, after a year of trying to right the ship with ...

The generic sterile injectables market accounted for $ 68.7 billion in 2019 and is estimated to be $196.2 billion by 2029 and is anticipated to register a CAGR of 11.2%, per a report from Prophecy ...

Over the past few years, drug shortages have become an ever-present challenge for hospital pharmacies, with shortages at their highest in over a decade1 and the majority of those, 53 percent, were for ...

What Endo thought was a real deal has turned into a kill deal. The Dublin-based Endo and its Par sterile injectables subsidiaries Wednesday said a $190 million agreement to buy sterile injectables ...

GREENVILLE, S.C. and SACRAMENTO, Calif., Jan. 6, 2026 /PRNewswire/ -- PAI Pharma ("PAI"), a portfolio company of Olympus Partners and a leading U.S. developer, manufacturer and marketer of oral liquid ...

Dublin, Dec. 16, 2019 (GLOBE NEWSWIRE) -- The "Sterile Injectable Drug Product Manufacturing Market Overview and Outlook" report has been added to ResearchAndMarkets.com's offering. Current demand for ...

PAI Pharma has acquired Nivagen Pharmaceuticals in a move it said was aimed at expanding the domestic supply of sterile injectable drugs. Nivagen operates a recently built aseptic manufacturing ...

WuXi STA launched a high potency, fully-automated sterile injectable manufacturing line at its drug product site in Wuxi City, China. The new line has an annual capacity of 12 million units and meets ...

The investment includes the installation of a high-speed, state-of-the-art Groninger UFVN FlexFill syringe, cartridge, and vial filling line and a SKAN isolator to enhance production efficiency and ...

Appointment Enhances Leadership Team with Deep Sterile Injectables Expertise and Ability to Drive the Company's Global R&D Strategy and Execution ST. LOUIS, Jan. 12, 2026 /PRNewswire/ -- Par Health, ...

Thanks to a new injectable formula, Brazilian researchers have succeeded in enhancing the efficacy and prolonging the duration of action of a drug commonly used to treat joint inflammation. The ...

The MarketWatch News Department was not involved in the creation of this content. GREENVILLE, S.C. and SACRAMENTO, Calif., Jan. 6, 2026 /PRNewswire/ -- PAI Pharma ("PAI"), a portfolio company of ...